These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15825414)

  • 1. Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis, and patients on chronic hemodialysis.
    Jaffe G; Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1974 Jun; 5(6):611-6. PubMed ID: 15825414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.
    Malacoff RF; Finkelstein FO; Andriole VT
    Antimicrob Agents Chemother; 1975 Nov; 8(5):574-80. PubMed ID: 1211913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of theophylline in peritoneal dialysis and hemodialysis.
    Lee CS; Peterson JC; Marbury TC
    J Clin Pharmacol; 1983 Jul; 23(7):274-80. PubMed ID: 6886029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.
    Ahern MJ; Finkelstein FO; Andriole VT
    Antimicrob Agents Chemother; 1976 Sep; 10(3):457-61. PubMed ID: 984787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefamandole in patients with renal failure.
    Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1977 Feb; 11(2):248-50. PubMed ID: 848929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intravenously administered tobramycin in normal volunteers and in renal-impaired and hemodialyzed patients.
    Péchère JC; Dugal R
    J Infect Dis; 1976 Aug; 134 Suppl():S118-24. PubMed ID: 972269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.
    Giron JA; Meyers BR; Hirschman SZ; Srulevitch E
    Antimicrob Agents Chemother; 1981 Feb; 19(2):279-83. PubMed ID: 6214987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic Dosing in Chronic Kidney Disease and End-Stage Renal Disease: A Focus on Contemporary Challenges.
    Vilay AM
    Adv Chronic Kidney Dis; 2019 Jan; 26(1):61-71. PubMed ID: 30876619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment.
    Rubino CM; Bhavnani SM; Loutit JS; Lohse B; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
    Manley HJ; Bailie GR; Frye R; Hess LD; McGoldrick MD
    J Am Soc Nephrol; 2000 Jul; 11(7):1310-1316. PubMed ID: 10864588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dialysis-associated bacterial infections].
    Saito A; Watanabe S
    Nihon Rinsho; 1992 Jan; 50 Suppl():744-50. PubMed ID: 1578760
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of multiple-dose cefoperazone in hemodialysis patients.
    Spyker DA; Richmond JD; Scheld WM; Bolton WK
    Am J Nephrol; 1985; 5(5):355-60. PubMed ID: 4061504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease.
    Halstenson CE; Hirata CA; Heim-Duthoy KL; Abraham PA; Matzke GR
    Antimicrob Agents Chemother; 1990 Jan; 34(1):128-33. PubMed ID: 2327747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C
    Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative characteristics of the methods for assessing aminoglycoside extraction with the artificial kidney tobramycin clearance and dialyzability].
    Firsov AA; Bogomolova NS; Treskina OS; Belorusov OS; Egorenko GG
    Antibiotiki; 1981 Apr; 26(4):290-7. PubMed ID: 7235670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.